AK-Spore HC Ointment 400 UNT / 1 % / 3.5 mg / 10,000 UNT per GM Ophthalmic Ointment
RxNorm 688663

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 688663 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: AK-Spore HC Ointment 400 UNT / 1 % / 3.5 mg / 10,000 UNT per GM Ophthalmic Ointment.

The following semantic concepts and normalized strings are associated with this clinical entity:

SY
AK-Spore HC Ointment (bacitracin 0.4 UNT/MG / hydrocortisone 1 % / neomycin 0.35 % / polymyxin B 10 UNT/MG) Ophthalmic Ointment
AUI:3547819
SY
AK-Spore HC Ointment (bacitracin 400 UNT / hydrocortisone 10 mg / neomycin 3.5 mg / polymyxin B 10,000 UNT) per GM Ophthalmic Ointment
AUI:3629317
PSN
AK-Spore HC Ointment 400 UNT / 1 % / 3.5 mg / 10,000 UNT per GM Ophthalmic Ointment
AUI:8244795
SBD
Bacitracin 0.4 UNT/MG / hydrocortisone 0.01 mg/MG / neomycin 0.0035 mg/MG / polymyxin B 10 UNT/MG Ophthalmic Ointment [AK-Spore HC Ointment]
AUI:12362997

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SY

Synonym (SY):
AK-Spore HC Ointment (bacitracin 0.4 UNT/MG / hydrocortisone 1 % / neomycin 0.35 % / polymyxin B 10 UNT/MG) Ophthalmic Ointment
(Atom ID: 3547819)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
AK-Spore HC Ointment (bacitracin 0.4 UNT/MG / hydrocortisone 1 % / neomycin 0.35 % / polymyxin B 10 UNT/MG) Ophthalmic Ointment
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
688663
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
3547819
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
688663
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

SY

Synonym (SY):
AK-Spore HC Ointment (bacitracin 400 UNT / hydrocortisone 10 mg / neomycin 3.5 mg / polymyxin B 10,000 UNT) per GM Ophthalmic Ointment
(Atom ID: 3629317)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
AK-Spore HC Ointment (bacitracin 400 UNT / hydrocortisone 10 MG / neomycin 3.5 MG / polymyxin B 10,000 UNT) per GM Ophthalmic Ointment
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
688663
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
3629317
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
688663
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

PSN

Prescribable Name (PSN):
AK-Spore HC Ointment 400 UNT / 1 % / 3.5 mg / 10,000 UNT per GM Ophthalmic Ointment
(Atom ID: 8244795)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
AK-Spore HC Ointment 400 UNT / 1 % / 3.5 MG / 10,000 UNT per GM Ophthalmic Ointment
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
688663
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
8244795
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
688663
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

SBD

Semantic Branded Drug (SBD):
Bacitracin 0.4 UNT/MG / hydrocortisone 0.01 mg/MG / neomycin 0.0035 mg/MG / polymyxin B 10 UNT/MG Ophthalmic Ointment [AK-Spore HC Ointment]
(Atom ID: 12362997)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
bacitracin 0.4 UNT/MG / hydrocortisone 0.01 MG/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG Ophthalmic Ointment [AK-Spore HC Ointment]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
688663
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12362997
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBD
Semantic Branded Drug (Ingredient + Strength + Dose Form + Brand Name)
Source Code
688663
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AI
{328185} 7300
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{328475} 388
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{335957} 11417
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{339972} 5492
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{328185} 7299
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{328475} 8536
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{335957} 1291
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{339972} 5492
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{328185} AM
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{328475} AM
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{335957} AM
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{339972} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN OBSOLETED
04/30/2020
Date the RxNorm atom became obsolete
RXTERM FORM
Ointment
The RxTerm dose form name for this drug